« FDA Approvals - Affymax(R) Announces Phase 3 Development Plan for Hematide(TM) (Business Wire | Main | FDA Clears for Marketing First Quick Test for Malaria The »

Theralase Technologies Inc. Extends Closing of Equity Financing (CNW Group


Theralase Technologies Inc. Extends Closing of Equity Financing (CNW Group via Yahoo! Finance)
Theralase Technologies Inc. announces that it will extend the closing date of its previously announced equity financing of up to $5 million CDN for up to thirty days from the date of this release.
 

©2006 FDA-News.com. All rights reserved.